Literature DB >> 10663910

Molecular basis of cardiac hypertrophy.

T Yamazaki1, Y Yazaki.   

Abstract

Cardiac hypertrophy is an adaptive process to an increased hemodynamic overload. When cardiomyocytes cultured on silicone dishes were stretched, second messengers such as protein kinase C (PKC), Raf-1 kinase, and mitogen-activated protein (MAP) kinases were activated, which were followed by increased protein synthesis. Moreover, pretreatment with an angiotensin II (AngII) type 1 receptor antagonist dimished an increase in protein synthesis, MAP kinase activity, and c-fos gene expression induced by the stretching of cardiomyocytes. These suggest the linkage of the cardiac renin-angiotensin system to the formation of pressure-overload hypertrophy. Indeed, in the stretch-conditioned medium the levels of AngII concentration were increased. Also, mechanical stretch enhanced endothelin (ET)-1 release from the cardiomyocytes and activated the Na(+)/H(+) exchanger independently of these vasoactive peptides. In the second part, we examined AngII-induced signaling pathways both in cardiac myocytes and in cardiac fibroblasts. AngII-evoked signal transduction pathways differed between cell types. In cardiac fibroblasts AngII activated MAP kinases through a pathway including the Gbetagamma subunit of Gi protein, Src, Shc, Grb2, and Ras, while Gq and PKC activation was necessary in cardiac myocytes. We further explored norepinephrine (NE)-induced signaling pathways in cardiac myocytes. NE activated Raf-1 kinase and MAP kinases and increased amino acid uptake in cardiomyocytes of neonatal rats. beta-adrenoceptor (AR) stimulation as well and alpha1-AR stimulation was involved in NE-induced MAP kinase activation. It is noteworthy that unlike in other cell types not only PKC activation but also protein kinase A (PKA) activation increased the activities of Raf-1 kinase and MAP kinases in cardiac myocytes and induced cell growth. Finally, we observed that beta-AR-induced activation of MAP kinases is dependent on both Gs/cAMP/PKA and Gi/Src/Ras signaling pathways and that phosphorylation of beta-AR is critical to the cross talk between these signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663910     DOI: 10.1007/s003920050001

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  11 in total

1.  Modeling hypertrophic IP3 transients in the cardiac myocyte.

Authors:  Michael Cooling; Peter Hunter; Edmund J Crampin
Journal:  Biophys J       Date:  2007-08-10       Impact factor: 4.033

2.  Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.

Authors:  Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2011-07-01       Impact factor: 2.581

3.  Regulation of protein kinase C isozymes in volume overload cardiac hypertrophy.

Authors:  Martin U Braun; Paul LaRosée; Gregor Simonis; Mathias M Borst; Ruth H Strasser
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

4.  Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.

Authors:  Jaime S Horton; Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

Review 5.  Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.

Authors:  Zaid Abassi; Ilia Goltsman; Tony Karram; Joseph Winaver; Aaron Hoffman
Journal:  J Biomed Biotechnol       Date:  2011-01-11

6.  Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.

Authors:  Mai Chen; Jiajia Xin; Baohui Liu; Liyang Luo; Jiayi Li; Wen Yin; Mingkai Li
Journal:  J Am Heart Assoc       Date:  2016-07-29       Impact factor: 5.501

7.  Cardiovascular outcomes related to social defeat stress: New insights from resilient and susceptible rats.

Authors:  Gessynger Morais-Silva; Willian Costa-Ferreira; Lucas Gomes-de-Souza; Jacqueline C Pavan; Carlos C Crestani; Marcelo T Marin
Journal:  Neurobiol Stress       Date:  2019-06-06

8.  The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.

Authors:  Laura Mele; Lauren J Maskell; Daniel J Stuckey; James E Clark; Richard J Heads; Vishwanie S Budhram-Mahadeo
Journal:  Cell Death Dis       Date:  2019-08-14       Impact factor: 8.469

9.  Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.

Authors:  Yumei Feng; Chetan Hans; Elizabeth McIlwain; Kurt J Varner; Eric Lazartigues
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Reciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes.

Authors:  Tushi Singal; Naranjan S Dhalla; Paramjit S Tappia
Journal:  J Cell Mol Med       Date:  2009-06-16       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.